BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6327479)

  • 1. Ranitidine: prophylaxis of duodenal ulcer recurrence.
    Lee FI; Fielding JD; Holmes GK; Hine KR; Gibson JA; Lochee-Bayne E; Mackay C; Mitchell KG; Pickard WR; Orchard RT
    Hepatogastroenterology; 1984 Apr; 31(2):85-7. PubMed ID: 6327479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ranitidine and cimetidine maintenance treatment of duodenal ulcer.
    Walt RP; Hunt RH; Misiewicz JJ; Trotman I; Colley S; Dewar EP; Frost RA; Shepherd TH; Golding PL; Colin-Jones DG
    Scand J Gastroenterol; 1984 Nov; 19(8):1045-7. PubMed ID: 6099915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of ranitidine maintenance treatment of duodenal ulcer.
    Boyd EJ; Wilson JA; Wormsley KG
    Scand J Gastroenterol; 1984 May; 19(3):394-400. PubMed ID: 6330871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dose comparative study with ranitidine in the therapy and prevention of duodenal ulcer].
    Paul F; Neuhaus H; Homann J; Kamenisch W; Eimiller A
    Z Gastroenterol; 1986 Mar; 24(3):141-8. PubMed ID: 3085363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer.
    Van Deventer GM; Elashoff JD; Reedy TJ; Schneidman D; Walsh JH
    N Engl J Med; 1989 Apr; 320(17):1113-9. PubMed ID: 2651924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking as a risk factor for duodenal ulcer relapse. RUDER Study Group.
    Breuer-Katschinski BD; Armstrong D; Goebell H; Arnold R; Classen M; Fischer M; Blum AL
    Z Gastroenterol; 1995 Sep; 33(9):509-12. PubMed ID: 8525653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative therapeutic trial of sucralfate and ranitidine in initial healing and relapse rate of duodenal ulcer.
    Agrawal BK; Prasad RN; Kumar P
    J Assoc Physicians India; 1990 Sep; 38 Suppl 1():720-2. PubMed ID: 2092028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine in the maintenance therapy of gastro-duodenal ulcer disease: Polish open multicentre study.
    Gibiński K; Nowak A; Gabryelewicz A; Szałaj W; Hasik J; Klincewicz H; Butruk E; Kosecki P; Pokora J; Radwan P
    Hepatogastroenterology; 1984 Aug; 31(4):180-2. PubMed ID: 6090287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A single evening dose of 300 mg ranitidine in the treatment of acute attacks of gastric and duodenal ulcers. Evaluation of 1,208 patients].
    Bories P; Tournade JM; Alberola B; Pappo M
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):227-32. PubMed ID: 3061358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective study of duodenal ulcer. Analysis of prognostic factors].
    Guerreiro S; Neves B; Va S; Pires M; Gouveia A; Quina M
    Acta Med Port; 1991; 4(4):191-7. PubMed ID: 1767711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine and antacids in the prevention of duodenal ulcer relapse in Greece.
    Kalantzis N; Theodoropoulos G; Katsaros D; Tzivras M; Fertakis A; Archimandritis A
    Hepatogastroenterology; 1992 Jun; 39(3):277-9. PubMed ID: 1505904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nizatidine in the short-term treatment of duodenal ulcer--an Italian Multicenter Study.
    Bovero E; Poletti M; Boero A; Mura BC; Camarri E; Corradini P; Corsini G; Federici G; Curzio M; Gianquinto G
    Hepatogastroenterology; 1987 Dec; 34(6):269-71. PubMed ID: 2892768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer.
    Farley A; Lévesque D; Paré P; Thomson AB; Sherbaniuk R; Archambault A; Mahoney K
    Am J Gastroenterol; 1985 Sep; 80(9):665-8. PubMed ID: 3898818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine in the treatment of peptic ulcer.
    Makalinao AU; Zaño FM
    Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled study with ranitidine for the prevention of recurrent duodenal ulcer].
    Ocaña Andrade E; Porras Katz JC; Beltrán Escobar G; Jáuregui Garduño JL
    Rev Gastroenterol Mex; 1997; 62(2):94-7. PubMed ID: 9471669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triletide and ranitidine for the management of chronic duodenal ulcer: a controlled clinical investigation.
    Gandolfi L; Solmi L
    Pharmatherapeutica; 1985; 4(3 Spec No):182-8. PubMed ID: 3903787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the inhibition of nocturnal gastric acid secretion the most important factor in duodenal ulcer treatment? A comparison between the effectiveness of single morning and nocte doses of ranitidine 300 mg.
    Zaterka S; Massuda HK; Eisig JN; Chinzon D; Bettarello A
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):185-8. PubMed ID: 2700103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of duodenal ulceration in patients on maintenance ranitidine.
    Marks IN; Wright JP; Girdwood AH; Lucke W
    S Afr Med J; 1984 Jun; 65(25):1010-1. PubMed ID: 6328686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interim analysis of a comparative trial of ranitidine and cimetidine in the prevention of duodenal ulcer.
    Gough KR
    Am J Med; 1984 Nov; 77(5B):39-42. PubMed ID: 6095660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal behaviour of healed duodenal ulcer.
    Gupta AK; Pal LS
    J Indian Med Assoc; 1998 Apr; 96(4):106-8. PubMed ID: 9844330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.